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A B S T R A C T
Between January 1st 1990 and December 31st 1999, 24 patients affected by Klatskin
tumor underwent operation in our department of surgery. According to Bismuth’s clas-
sification, there were 0 (0%) type I, 5 (21%) type II, 6 (25%) type IIIa, 4 (17%) type IIIb
and 9 (37%) type IV tumors. Five patients (21%) were treated by curative resection
(group I) while in 14 patients (58%) palliative surgical procedure was performed (group
II). In 5 cases (21%) the extension of malignancy did not allowed any procedure (group
III). Curative resection for malignant tumors of the hepatic duct bifurcation included
wide tumor excision and bile duct resection at the liver hilum (with »wedge« hepatic re-
section in one patient) and creation of biliary-enteric anastomosis. Palliative surgical
procedure included stent insertion. Jaundice was completely relieved in all patients un-
dergoing resection, since 3 patients (21%) after stenting hadn’t satisfactory biliary drai-
nage. There was 1 (20%) perioperative death in the group 1, while in group 2, 5 patients
(36%) died postoperatively. In this series, the mean postoperative survival of all patients
was 16 months. The mean postoperative survival of patients undergoing localized tu-
mor resection with curative intent was 38 months, in contrast to 10 months for those un-
dergoing operative stent insertion. In addition, only 1 patient from group III, in whom
only exploratory surgery were performed survived 7 months, while other 4 patients died
in the hospital. This retrospective review suggests that aggressive surgical treatment
could improve survival and quality of life in patients suffering from Klatskin tumor.
Key words: Klatskin tumor, cholangiocarcinoma, ERCP (endoscopic retrograde cho-
langiopancreatography)
317
Received for publication April 3, 2003
Introduction
Cholangiocarcinoma is rare tumor with
an incidence of 2–4/100,000 per year1, ac-
counting for less than 2% of all human
malignancies2. Although this disease can
occur at any site in the biliary tree, tu-
mors involving the biliary confluence or
the right or left hepatic ducts (Klatskin
tumor) are most common and account for
40%–60% of all cases3,4. Although the ex-
act cause of Klatskin tumor is unknown,
it is believed that gallstones by repeated
trauma and chronic inflammation might
increase the risk of this disease5. In the
absence of specific clinical symptoms,
early diagnosis is delayed. Usually symp-
toms like jaundice, pain, and weight loss
that are caused by tumor progression, di-
rect the diagnosis towards perihilar tu-
mor6. This long asymptomatic course of
Klatskin tumor is cause for only 20%
resectable patients at the time of diagno-
sis1. On the other hand, surgery offers the
only chance for cure and long-term sur-
vival because neither chemotherapy nor
radiation therapy improves the length or
quality of survival7. The remaining 80%
of patients with advanced unresectable
carcinoma have a dismal prognosis with
an overall survival rate of only 6–8
months1. The main symptom requiring
treatment in these patients is jaundice
due to extrahepatic biliary obstruction
and it can be achieved by palliative proce-
dures like endoscopic, percutaneous and
surgical stenting or by surgical biliodige-
stive anastomosis. The aim of this study
is to report the results of 24 patients that
were surgically treated for carcinoma at
the hepatic duct bifurcation, and by anal-
ysis of the literature, to emphasize the
progress of the surgical treatment in hi-
lar tumor.
Material and Methods
We retrospectively reviewed the clini-
cal courses of 24 consecutive patients
with the tumor of the hepatic duct bifur-
cation treated between 1990 and 2000 at
the Department of Surgery, University
hospital »Sestre milosrdnice«, Zagreb,
Croatia. Patients ranged in age from 52
to 84 years (mean: 69 years of age), with
11 women (46%) and 13 men (54%). Clini-
cal presentation was typically that of ob-
structive jaundice (Table 1). Duration of
symptoms before surgery ranged from 5
to 120 days (mean: 28 days). Initial pa-
tient assessment included a complete his-
tory and physical examination, assess-
ment of general health, and review of
imaging studies. Most patients (92%)
were referred to us from Department of
Internal Medicine with usual radiogra-
phic evaluation consisting of a computed
tomographic scan in 13 (54%) patients,
ultrasound in 19 (79%) and endoscopic
retrograde cholangiopancreatography
(ERCP) in 12 (50%) patients. Two pa-
tients were emergency operated after
only abdominal ultrasound examination
because of high suspicion on acute cal-
culos cholecystitis and choledocholithia-
sis. Usual ultrasound and tomographic
findings were obstruction of the extrahe-
patic biliary tract with a decompressed
common bile duct and gallbladder, while
ERCP revealed cut-off or high grade ste-
nosis of the common hepatic duct at the
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TABLE 1












level of the hepatic duct bifurcation. In no
of these 22 patients there was no evi-
dence of tumor extension within the bi-
liary tree, vascular and nodal involve-
ment or metastatic disease on radiogra-
phy’s images. Therefore all patients in
our study underwent exploratory surgery
with curative intent. Before surgery, pre-
operative evaluation with a chest radio-
graph, routine laboratory studies, and as-
sessment by an anesthesiologist were
done in all the patients. At operation full
abdominal exploration was firstly perfor-
med to exclude disseminated disease. Lo-
cation of the tumor at the hilum of the
liver was identified by palpation. In 5
cases (21%) no procedure could be per-
formed because of disseminated or locally
advanced malignancy. Palliative surgical
procedure that included insertion of the
stent in the left or right hepatic duct was
performed in 14 patients (58%). Remai-
ning five patients (21%) underwent cura-
tive surgical procedure. In this operation,
cholecystectomy was initially performed
to expose the hilum. The common bile
duct distal to the tumor after dissection
from the hepatic artery and portal vein
was divided and oversewn following by
resection of the entire extrahepatic bi-
liary apparatus together with the tumor,
and clearance of all lymph nodes within
the hepatoduodenal ligament to the level
of the common hepatic artery. Finally,
continuity was established by creation of
Roux-en-Y biliary-enteric anastomosis to
a segment of jejunum. In one patient
from this group »wedge« resection of liver
metastasis were performed in addition to
resection of extrahepatic billiary appara-
tus. Data were collected from admission
record, surgeon’s and anesthesiologist’s
reports, ICU patient’s status sheets,
blood tests and pathohystologycal exami-
nation of the removed specimens. Differ-
ences were analyzed by using the student
t-test. Values of p<0.05 were chosen to
identify statistical significance.
Results
The median duration of surgery was
110 minutes. It was longer in the group of
patients treated by curative resection
(group 1) and this difference was statisti-
cally significant (p<0.001). 50 % of pa-
tients required transfusion of blood prod-
ucts during the surgery and the median
blood replacement was 230 (460 to 2030)
ml. Although the use of blood products
was greater in the resection group than
in the patients who did undergo only pal-
liative stenting (group 2), difference was
not statistically significant (p<0.05). The
median hospital stay was 14 days (range 1
to 56 days) and although longer in the re-
section group, different between the two
groups was not significant (p>0.05) (Table 2).
According to the Bismuth-Corlette
classification of tumor location and ex-
tent within the biliary tree, there were to-
tal of 0 (0%) BI, 5 (21%) BII, 6 (25%)
BIIIa, 4 (17%) BIIIb and 9 (37%) BIV tu-
mors. With regard to surgical procedure,
there were 1 (20%) of BIBII and 4 (80%)
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TABLE 2
DIFFERENCES BETWEEN TWO GROUP IN DURATION OF SURGERY,






Median duration of surgery (minutes) 260 (170–350) 110 (60–150) <0.001
Median blood replacement (ml) 920 (460–2030) 780 (570–1320) >0.05
Median hospital stay (days) 21 (7–30) 14 (4–56) >0.05
of BIIIBIV tumors in the resection group
while in palliative group there were 4
(29%) BIBII and 10 (71%) BIIIBIV tu-
mors (Table 3).
Fourteen patients had metastatic dis-
ease: 4 to the liver, 5 to N2 level lymph
nodes, 4 to the liver and N2 lymph nodes,
and 1 to the peritoneum, liver and N2
lymph nodes (Table 4). The overall fre-
quency of nodal metastases was 14 (58%).
In the group of patients treated by pal-
liative stenting, complications occurred
in 6 (43%) patients: hepatic failure in 4,
cerebrovascular infarction (CVI) in 1 and
cardio-respiratory failure in 1. Operative
mortality was 5 (36%) (hepatic failure
due to stent afunction was the underlying
cause of death in 3 patients, massive CVI
in one patient and multi-organ system
failure in one).
In the resection group, postoperative
complications occurred in 1 (20%) patient
who died because of sepsis and
multi-organ system failure. Thus opera-
tive mortality in this group was 20%.
Mean survival for all patients was 16
months (range: 2 to 51 months; median:
10 months). Mean survival in the resec-
tion group (n=5) was 38 months (range:
18 to 51 months; median: 45 months). For
patients treated by palliative procedure
(n=14) mean survival was 10 months (ran-
ge: 2 to 30 months; median: 5 months). In
addition, only one patient who underwent
only exploration (n=5) survived 7 months
after discharging from hospital, while
other four patients died in the hospital
immediately after surgical exploration.
Discussion
Klatskin tumor has been recognized
as one of the most incurable lesions and
most difficult management problems fa-
ced by surgeons because of its anatomic
location close to vital structures8. It is
slow-growing tumor that is localized, scle-
rotic, hypocellular, and intramural, and
rarely reveals preoperative evidence of
metastatic disease. A variety of preopera-
tive imaging modalities have been used
to assess patients with this tumor. Unfor-
tunately, even after extensive preopera-
tive evaluation, occult unresectable dis-
ease is discovered at the time of explora-
tory laparotomy in more than 50% pa-
tients, respectively9. Tumor involvement
of the portal venous system is most im-
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TABLE 3
BISMUTH-CORLETTE CLASSIFICATION OF
TUMOR LOCATION AND IT’S EXTENSION







B I 0 (0) 0 (0) 0 (0)
B II 1 (20) 4 (28.6) 0 (0)
B IIIa 1 (20) 5 (35.7) 0 (0)
B IIIb 1 (20) 3 (21.4) 0 (0)
B IV 2 (40) 2 (14.3) 5 (100)
TABLE 4







Total 2 (40) 7 (50) 5 (100)
N2 lymph nodes 1 (20) 4 (29) 0 (0)
Liver 1 (20) 2 (14) 1 (20)
N2liver 0 (0) 1 (7) 3 (60)
N2liverperitoneum 0 (0) 0 (0) 1 (20)
portant determinant for irresectability,
which can often be assessed by duplex
Doppler US with accuracy of 91% com-
pared with surgical findings. Helical CT
is not so effective and it’s accuracy in as-
sessing of biliary extrahepatic and vascu-
lar involvement is about 60%9. Some au-
thors have brought staging laparoscopy
like preoperative procedure that correctly
identifies the majority of patients with
unresectable disease and prevents unnec-
essary laparotomy in one third of pa-
tients10,11. In our series, preoperative im-
aging studies usually consisted of a CT
scan, abdominal ultrasound and ERCP
were done in 22 patients (two patients
were emergency operated). In all patients
diagnostic evaluation revealed obstruc-
tion or stricture of extrahepatic bile duct
with no evidence of locally advanced or
metastatic disease. Thus, all patients in
our study were candidates for curative re-
section.
Treatment of obstructive jaundice due
to Klatskin cancer relieves pruritus, im-
proves appetite, and reduces fat mal-
absorption12. Since Gerald Klatskin13 in
1965 noticed increased duration of sur-
vival from 10 months to 23 months in pa-
tients who underwent successful decom-
pression, over the years aggressive sur-
gical therapy for this tumor has changed.
The disappointing outcome in patients
with Klatskin tumor arises from the diffi-
culty in completely excising of the tumor.
Because of high propensity to spread
proximally and distally within the bile
duct system14,15, it is common for these
tumors that surgical margins demonstra-
te residual microscopic tumor with peri-
neural or perivascular invasion. In our
research positive surgical margins were
found in 1 (20%) of 5 patients treated by
curative resection and this patient sur-
vived 18 months after curative resection.
According to Bismut et al16 microsco-
pic involvement of the resection margin is
the most important prognostic factor,
while local lymph node involvement does
not influence patients’ outcome and sur-
vival after curative resection for Klatskin
tumor. In view of this poor prognosis and
the likelihood of recurrent disease, pallia-
tive therapies have been advocated.
These include surgical palliation by cre-
ation of bilioenteric anastomosis or oper-
ative stent placement and nonsurgical
palliation by placing stents endoscopical-
ly or with radiologic guidance. Unfortu-
nately, these modalities fail to improve
survival despite temporary relief of the
biliary tract obstruction.
Several authors have demonstrated
significantly prolonged survival when re-
sectional therapy is included in the treat-
ment regiment17,18. In Childs’ study, mean
postoperative survival rates was 21.3
months in the group resected for cure and
12.4 months in those resected with pallia-
tive intent (resection margins were in-
volved with tumor on pathologic exami-
nation)18.
In our study, mean postoperative sur-
vival for patients treated by curative re-
section was 38 months and 10 months for
patients treated by operative stent inser-
tion. These data clearly demonstrates the
impact of curative resection of all visible
tumor with an en block lymphadenecto-
my on survival in patients suffering from
Klatskin tumor. Although this procedure
significantly prolonged duration of sur-
gery (260 min. vs. 110 min.), incidence of
postoperative complications (20% vs.
43%) and operative mortality (20% vs.
36%) were higher in palliative group.
Controversy exists as to whether more
radical resection, including hepatic lobe-
ctomy is indicated for treatment. Hepatic
resection is often performed in order to
obtain microscopic tumor-free margins
and curative resection. Siewert et al.19
achieved 54.8% R0 resection in 31 pa-
tients treated by extended, local and he-
patic resection. Two-and five-year survi-
val rates in his study were 53.9% and
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24.5%, respectively. Lygidakis et al.20 in
his study compared results between local
and extended procedure that included he-
mihepatectomy. Mean survival in pa-
tients treated by local resection was 29
months and 5-years survival rate 10%
compared with 39 months and 20% for
those patients treated by hemihepatec-
tomy. Therefore, combined tumor and
liver resection is associated with better
results when compared with those follow-
ing tumor resection alone. According to
Kawarada and Gadzijev21 in some pa-
tients, hilar bile duct carcinoma can eas-
ily spread to the bile duct branches of the
caudate lobe as well as to the bile duct
branches of the medial segment depend-
ing on anatomical variations of these
structures, and resection of the inferior
portion of the medial segment together
with a caudate lobectomy is then requi-
red for curative resection.
Many clinical trials showed prolonged
patency in expandable biliary stent used
to treat low-or distal-bile duct obstruc-
tion, but not in cases of obstruction by a
tumor involving the proximal biliary sys-
tem at or above the bifurcation of the
right and left hepatic ducts22. In our stu-
dy operative stent insertion had a limited
effect on long-term palliation and equally
had a low successful drainage rate. Na-
mely, in 3 (21%) patients from palliative
group progressive hepatic failure due to
complete stent afuncion resulted in death.
It is noteworthy that patients in our
study were not treated by preoperative
biliary drainage, and this fact may ex-
plain low operative morbidity and mor-
tality rate especially in resection group.
This is in accordance with findings of
MacPherson et al.23 who found increased
operative mortality and postoperative in-
fections complications, in previously
drained patients undergoing resection of
proximal bile duct cancers. In contrast,
preoperative ERCP were performed in 12
(50%) patients and following this proce-
dure we noticed one case of cholangytes.
Thus, incidence of cholangytes after the
ERCP procedure was 8.3% in our study.
In conclusion, results of our study
show that aggressive surgical treatment
could improve survival in patients suffer-
ing from Klatskin tumor. The major weak-
ness of this study is a small number of pa-
tients operated with curative intent.
Therefore conclusions based solely on the
statistical significance of the data pre-
sented in this study must be critically re-
viewed. Studies involving larger number
of patients are required before definite
judgment of the benefit of radical local re-
section for Klatskin tumor. Based on this
study, we favor radical resection of all vis-
ible tumor with an en block lymph node
dissection of the portal vein and proper
and common hepatic arteries to their ori-
gin. In the cases of Bismuth III–IV tu-
mors we support additional liver resec-
tion for the reason to achieve an RO
surgery. This surgical procedure is char-
acterized by high technical difficulties and
better results can be reached by hepato-
biliary surgical teams24.
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KLATSKIN TUMOR – REZULTATI KIRUR[KOG LIJE^ENJA
S A @ E T A K
U razdoblju od 1. sije~nja 1990. do 31. prosinca 1999. godine u na{oj Kirur{koj Klinici
operirano je ukupno 24 bolesnika s Klatskinovim tumorom. S obzirom na Bismuthovu
klasifikaciju pro{irenosti tumora, nijedan bolesnik u na{oj studiji nije imao tumor I.
stupnja pro{irenosti, dok je u 5 (25%) bolesnika tumor bio u II. stadiju, u 6 (25%) bo-
lesnika u III.a, u 4 (17%) bolesnika u III.b te u 9 (37%) bolesnika u IV. stadiju bolesti. 5
(21%) bolesnika bilo je podvrgnuto radikalnom operacijskom zahvatu (Grupa I) dok je
kod 14 (58%) bolesnika bio u~injen samo palijacijski kirur{ki zahvat (Grupa II). U pre-
ostalih 5 (21%) bolesnika uznapredovalost tumora nije dozvoljava bilo koji oblik ki-
rur{kog zahvata. Radikalni kirur{ki zahvat sastojao se od {iroke resekcije tumora i
`u~nih vodova (uz »wedge« resekciju jetrene presadnice kod jednog bolesnika) te krei-
ranja bilio – digestivnih anastomoza. Palijativni kirur{ki zahvat sastojao se od intra-
operativnog postavljanja stenta u desni ili lijevi jetreni vod. Ikterus kao vode}i
simptom ve}ine na{ih bolesnika, u potpunosti se povukao u svih bolesnika operiranih
radikalnim kirur{kim zahvatom dok kod 3 (21%) bolesnika nakon postavljanja stenta
nije do{lo do uspostave zadovoljavaju}e bilijarne drena`e. Jedan bolesnik iz grupe 1
(20%) te 5 bolesnika (36%) iz grupe 2 umrla su u postoperativnom periodu. Ukupno
srednje pre`ivljenje na{ih bolesnika je 16 mjeseci. Za bolesnike operirane radikalnim
kirur{kim zahvatom srednje vrijeme pre`ivljenja iznosilo je 38 mjeseci u odnosu na 10
mjeseci u bolesnika operiranih palijativnim kirur{kim zahvatom. Od 5 bolesnika iz
grupe III, ~etiri bolesnika su umrla tijekom postoperativnog perioda dok je samo jedan
bolesnik pre`ivio 7 mjeseci. Rezultati ove retrospektivne studije upu}uju na zaklju~ak
da radikalni kirur{ki zahvat u bolesnika s Klatskinovim tumorom produ`uje pre`iv-
ljenje i pobolj{ava kvalitetu `ivota.
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